Randomized trial · people

PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In premenopausal women, the higher PT-141 doses added a small gain in satisfying sexual events over placebo, and nausea, flushing and headache were the side effects that came up.

Kind
Randomized trial
Studied in
People
Number studied
327
Published
2016
Journal
Womens Health (Lond)

What they tested

The team tested whether bremelanotide (PT-141), used under the skin as needed, works and is safe for premenopausal women with female sexual dysfunctions, and which dose fits best.

How the study was done

A randomized, placebo-controlled dose-finding trial in premenopausal women with female sexual dysfunctions, with 327 women in the efficacy analysis. Women gave themselves a placebo (dummy shot) or PT-141 at 0.75, 1.25 or 1.75 mg under the skin when they chose to, over 12 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In the pooled 1.25 and 1.75 mg arms, satisfying sexual events rose by +0.7 a month from the start, compared with +0.2 on placebo (p = 0.0180). The total score on the female sexual function index went up +3.6 versus +1.9 (p = 0.0017). The total score on the female sexual distress scale for desire, arousal and orgasm changed by -11.1 versus -6.8 (p = 0.0014). The side effects named were nausea, flushing and headache.

What it doesn’t show

The trial ran 12 weeks and included only premenopausal women. The main comparison pooled the two higher doses against placebo rather than looking at each dose alone.

The paper

Clayton et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond). 2016.

The compound

More studies on PT-141

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo